Cargando…

Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!

INTRODUCTION: Perimenopause phase of a woman’s life is featured by decline in the ovarian activity, predisposing her to several health consequences. The signs and symptoms of thyroid disorders simulate those of menopausal features which may go unnoticed and can cause untoward complications in these...

Descripción completa

Detalles Bibliográficos
Autores principales: Usha, S. M. R., Bindu, C. M., Chandrika, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266572/
https://www.ncbi.nlm.nih.gov/pubmed/37324792
http://dx.doi.org/10.4103/jmh.jmh_67_22
_version_ 1785058765647642624
author Usha, S. M. R.
Bindu, C. M.
Chandrika, N.
author_facet Usha, S. M. R.
Bindu, C. M.
Chandrika, N.
author_sort Usha, S. M. R.
collection PubMed
description INTRODUCTION: Perimenopause phase of a woman’s life is featured by decline in the ovarian activity, predisposing her to several health consequences. The signs and symptoms of thyroid disorders simulate those of menopausal features which may go unnoticed and can cause untoward complications in these women. AIMS AND OBJECTIVE: The primary objective is to screen women of perimenopausal age for thyroid disorders. The secondary objective is to examine the variations in thyroid hormone levels in these women with advancing age. MATERIALS AND METHODS: One hundred and forty-eight apparently healthy women between the age group of 46 and 55 years were study subjects. They were divided into, Group I which constituted women between 46 and 50 years and Group II consisted of women between 51 and 55 years. Thyroid profile comprising serum thyroid-stimulating hormone (TSH), serum total triiodothyronine (T(3)), and serum total thyroxine (T(4)) were estimated for all the women recruited in the study. RESULTS: Subclinical hypothyroidism (SCH) and overt hypothyroidism (OH) were detected in 22 and 8 women who constituted 14.9% and 5.4%, respectively, of the total women populace. In Group I, it was noted that 17.1% and 1.8% of women were suffering from SCH and OH, respectively. In Group II, while 8.1% of the women had SCH, 16.2% of women had progressed to OH. TSH levels were significantly higher (P = 0.002) in women of Group II than in Group I, suggesting increase in TSH levels with advancing age. CONCLUSION: Screening of perimenopausal women for thyroid disorders will assure timely detection and proper management which will aid in reducing the morbidity and associated complications.
format Online
Article
Text
id pubmed-10266572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-102665722023-06-15 Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women! Usha, S. M. R. Bindu, C. M. Chandrika, N. J Midlife Health Original Article INTRODUCTION: Perimenopause phase of a woman’s life is featured by decline in the ovarian activity, predisposing her to several health consequences. The signs and symptoms of thyroid disorders simulate those of menopausal features which may go unnoticed and can cause untoward complications in these women. AIMS AND OBJECTIVE: The primary objective is to screen women of perimenopausal age for thyroid disorders. The secondary objective is to examine the variations in thyroid hormone levels in these women with advancing age. MATERIALS AND METHODS: One hundred and forty-eight apparently healthy women between the age group of 46 and 55 years were study subjects. They were divided into, Group I which constituted women between 46 and 50 years and Group II consisted of women between 51 and 55 years. Thyroid profile comprising serum thyroid-stimulating hormone (TSH), serum total triiodothyronine (T(3)), and serum total thyroxine (T(4)) were estimated for all the women recruited in the study. RESULTS: Subclinical hypothyroidism (SCH) and overt hypothyroidism (OH) were detected in 22 and 8 women who constituted 14.9% and 5.4%, respectively, of the total women populace. In Group I, it was noted that 17.1% and 1.8% of women were suffering from SCH and OH, respectively. In Group II, while 8.1% of the women had SCH, 16.2% of women had progressed to OH. TSH levels were significantly higher (P = 0.002) in women of Group II than in Group I, suggesting increase in TSH levels with advancing age. CONCLUSION: Screening of perimenopausal women for thyroid disorders will assure timely detection and proper management which will aid in reducing the morbidity and associated complications. Wolters Kluwer - Medknow 2022 2023-04-28 /pmc/articles/PMC10266572/ /pubmed/37324792 http://dx.doi.org/10.4103/jmh.jmh_67_22 Text en Copyright: © 2023 Journal of Mid-life Health https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Usha, S. M. R.
Bindu, C. M.
Chandrika, N.
Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!
title Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!
title_full Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!
title_fullStr Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!
title_full_unstemmed Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!
title_short Thyroid Dysfunction: An Alternate Plausibility in Perimenopausal Women!
title_sort thyroid dysfunction: an alternate plausibility in perimenopausal women!
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266572/
https://www.ncbi.nlm.nih.gov/pubmed/37324792
http://dx.doi.org/10.4103/jmh.jmh_67_22
work_keys_str_mv AT ushasmr thyroiddysfunctionanalternateplausibilityinperimenopausalwomen
AT binducm thyroiddysfunctionanalternateplausibilityinperimenopausalwomen
AT chandrikan thyroiddysfunctionanalternateplausibilityinperimenopausalwomen